| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |